In the preceding three months, 8 analysts have released ratings for Lexicon Pharmaceuticals (NASDAQ:LXRX), presenting a wide array of perspectives from bullish to bearish. The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months. Analysts’ evaluations of 12-month price targets offer additional insights, showcasing an average target of $10.0, with a high estimate of $10.00 and a low estimate of $10.00. No alteration is observed as the current average remains at the previous average price target. Invest…